Residual cholesterol inflammatory index and its prognostic role in mortality among individuals with cardiovascular–kidney–metabolic syndrome stages 0–3 based on U.S. and Chinese national cohorts
RCII is a strong predictor of mortality in CKM stages 0-3, potentially aiding risk assessment and early intervention.
Authors
- Zhengwen Xu
- Sijia Yu (ORCID: https://orcid.org/0000-0002-3937-6676)
- Chuan Qian (ORCID: https://orcid.org/0000-0003-0315-8893)
- Shouxin Wei (ORCID: https://orcid.org/0009-0006-8882-4443)
- Yindong Jia
Institutions
- Suizhou Central Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1186/s40001-025-03615-y
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05